<DOC>
	<DOCNO>NCT00130858</DOCNO>
	<brief_summary>Phase II Study evaluate response two block topotecan carboplatin</brief_summary>
	<brief_title>Multicenter Clinical Trial Treatment Children Adolescents With Soft Tissue Sarcoma Stage 4</brief_title>
	<detailed_description>Phase II study patient chemosensible soft tissue sarcoma stage IV child adolescent ; response accord RECIST criterion follow two block combination therapy consist Topotecan carboplatin</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Soft tissue sarcoma chemosensible , stage IV age &lt; 21 measurable tumor lesion Lack cooperation patient willingness followup examination participation another clinical trial time death due sickness within four week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Sarcoma , Soft Tissue</keyword>
</DOC>